Replies to post #195825 on Biotech Values

[north40000]

Is the Cabilley patent of DNA-still alive after AMGN and Medimmune suits? Expires in 2017, from memory.

[DewDiligence]

Re: PD-L1 expression

With each PD-1/PD-L1 drug using a different companion diagnostic and hence a different definition of PD-L1 positivity, comparisons across clinical trials for these agents are going to be even trickier than such comparisons usually are.